Thomas Stephen Basil
Climb Bio, Inc. · Director
Thomas Stephen Basil is listed in filings as Director at Climb Bio, Inc.. This profile follows SEC Form 4 activity through Feb 27, 2026, including sale activity. Recent filings connect the profile to Climb Bio, Inc. (CLYM). The current snapshot covers public activity from Jan 3, 2025 to Feb 27, 2026. Reported amounts are shown as $114.3K to $58.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $236k33.7k shares | SellFeb 25, 2026 | $7.00 | $11.34 | |
| $58k10k shares | SellFeb 13, 2026 | $5.81 | $11.34 | |
| $471k90k shares | SellFeb 12, 2026 | $5.23 | $11.34 |